Doxazosin mesylate and Deformity - a phase IV clinical study of FDA data

Summary:

Deformity is reported as a side effect among people who take Doxazosin mesylate (doxazosin mesylate), especially for people who are female, 60+ old, also take Magnevist, and have Gout.

The phase IV clinical study analyzes which people have Deformity when taking Doxazosin mesylate. It is created by eHealthMe based on reports of 11,237 people who have side effects when taking Doxazosin mesylate from the FDA, and is updated regularly.

What is Doxazosin mesylate?

Doxazosin mesylate has active ingredients of doxazosin mesylate. It is often used in high blood pressure. eHealthMe is studying from 11,975 Doxazosin mesylate users. Check the latest studies of Doxazosin mesylate.

What is Deformity?

Deformity (disfigurement) is found to be associated with 930 drugs and 697 conditions by eHealthMe. Check the latest studies of Deformity.

On Jul, 10, 2026

11,237 people reported to have side effects when taking Doxazosin mesylate.
Among them, 16 people (0.14%) have Deformity.

Could Doxazosin mesylate cause Deformity?

Among these 16 people:

What is the gender of people who have Deformity when taking Doxazosin mesylate? *

female: 56.25 %
male: 43.75 %

What is the age of people who have Deformity when taking Doxazosin mesylate? *

What are other drugs people take besides Doxazosin mesylate? *

What are other side effects people have besides Deformity? *

Pain: 16 people, 100.00%
Oedema Peripheral (superficial swelling): 14 people, 87.50%
Scar: 13 people, 81.25%
Emotional Distress: 13 people, 81.25%
General Physical Health Deterioration (weak health status): 13 people, 81.25%
Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 13 people, 81.25%
Skin Hypertrophy (skin cells enlarges): 12 people, 75.00%
Stress And Anxiety: 12 people, 75.00%
Mobility Decreased (ability to move is reduced): 12 people, 75.00%
Joint Contracture (a permanent shortening of a muscle or joint): 10 people, 62.50%

What are the existing conditions these people have? *

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 12.50%
Gout (uric acid crystals building up in the body): 2 people, 12.50%
Nuclear Magnetic Resonance Imaging Brain: 1 person, 6.25%
Bone Neoplasm Malignant (cancer of bone): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Doxazosin mesylate and have Deformity?

- Check whether Deformity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Doxazosin mesylate:

Doxazosin mesylate (11,975 reports)

Deformity treatments and more:

Deformity (13,758 reports)

Browse all side effects of Doxazosin mesylate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Deformity:

Deformity (930 drugs)

Browse all the conditions that are associated with Deformity:

Deformity (697 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on doxazosin mesylate (the active ingredients of Doxazosin mesylate) and Doxazosin mesylate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.